These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15265536)

  • 1. Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.
    Banks WA; Niehoff ML; Zalcman SS
    Brain Behav Immun; 2004 Sep; 18(5):434-42. PubMed ID: 15265536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.
    Banks WA; Ortiz L; Plotkin SR; Kastin AJ
    J Pharmacol Exp Ther; 1991 Dec; 259(3):988-96. PubMed ID: 1762091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesfatin-1 crosses the blood-brain barrier without saturation.
    Pan W; Hsuchou H; Kastin AJ
    Peptides; 2007 Nov; 28(11):2223-8. PubMed ID: 17950952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
    Nonaka N; Shioda S; Banks WA
    Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha.
    Lee NY; Kang YS
    Brain Res; 2004 Oct; 1023(1):141-7. PubMed ID: 15364029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate modulation of IL-1alpha, IL-2, and TNF-alpha transport across the blood-brain barrier.
    Lynch JL; Banks WA
    Brain Behav Immun; 2008 Oct; 22(7):1096-1102. PubMed ID: 18502094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
    Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
    Isakovic AJ; Abbott NJ; Redzic ZB
    J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
    Nonaka N; Shioda S; Niehoff ML; Banks WA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agouti-related protein(83-132) aggregates and crosses the blood-brain barrier slowly.
    Kastin AJ; Akerstrom V; Hackler L
    Metabolism; 2000 Nov; 49(11):1444-8. PubMed ID: 11092509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human interleukin-1 alpha crosses the blood-testis barriers of the mouse.
    Banks WA; Kastin AJ
    J Androl; 1992; 13(3):254-9. PubMed ID: 1601745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIT-082, a cognitive enhancer, is transported into brain by a nonsaturable influx mechanism and out of brain by a saturable efflux mechanism.
    Taylor EM; Yan R; Hauptmann N; Maher TJ; Djahandideh D; Glasky AJ
    J Pharmacol Exp Ther; 2000 Jun; 293(3):813-21. PubMed ID: 10869380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1.
    Price TO; Samson WK; Niehoff ML; Banks WA
    Peptides; 2007 Dec; 28(12):2372-81. PubMed ID: 18006117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
    Pan W; Banks WA; Kastin AJ
    Exp Neurol; 1997 Aug; 146(2):367-73. PubMed ID: 9270046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system.
    Waguespack PJ; Banks WA; Kastin AJ
    Brain Res Bull; 1994; 34(2):103-9. PubMed ID: 8044683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine.
    Lockman PR; Van der Schyf CJ; Abbruscato TJ; Allen DD
    J Neurochem; 2005 Jul; 94(1):37-44. PubMed ID: 15953347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFalpha and the blood-brain barrier: accumulation in cerebral vasculature.
    Pan W; Vallance K; Kastin AJ
    Exp Neurol; 1999 Dec; 160(2):454-9. PubMed ID: 10619562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.